It picked up the tab at Daniel and Peter Luger, but the inducements for doctors didn’t end with those New York restaurants.
With nearly decade-old bribery charges hanging over its head, Novartis has been eager to wriggle out of U.S. prosecutors’ crosshairs. Now, a settlement appears to be in the works—and it could cost Novartis close to a billion dollars.
As massive marketing crackdowns and kickback lawsuits circulate through U.S. courtrooms, scrutiny on pharma's financial ties to healthcare providers has never been higher. But instead of scaling back its payments to docs and hospitals last year, Big Pharma leaned in even further.
After six years of legal wrangling and unflattering headlines, Novartis appears close to putting a doctor kickback lawsuit behind it—and the revelation came from a court filing that was supposed to be kept secret.
Il Rapporto benazepril Market offre spunti approfondite sui principali driver, le opportunità, le sfide, le tendenze del settore e il loro impatto sul mercato. Il rapporto benazepril mercato offre anche profilatura strategica dei giocatori chiave. Questo rapporto offre anche i dati sul Pricing Strategy, Brand Strategy, e Target client associati con benazepril mercato. Inoltre fornisce distributori / commercianti Lista offerti dalla società. Questo rapporto di ricerca coinvolge anche laccento sulla storica con entrate previste dei segmenti di mercato e tassi di crescita previsti. Gli elementi principali di guida e che incidono dati di mercato di crescita e di analisi sono derivati ??da una combinazione di fonti primarie e secondarie.
Enforcement Report - Week of November 28, 2018
Enforcement Report - Week of May 23, 2018
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.